The FDA has paused @biontechse.bsky.social's Phase I/IIa trial of its malaria vaccine, BNT165e, amid unspecified concerns. With over 180 participants in the trial, the vaccine aims to combat malaria using mRNA technology. #IDsky #MEDsky
Read here: https://www.contagionlive.com/view/fda-pauses-biontech-s-malaria-vaccine-trial-amid-broader-vaccine-challenges
Read here: https://www.contagionlive.com/view/fda-pauses-biontech-s-malaria-vaccine-trial-amid-broader-vaccine-challenges
Comments